Psimei Pharmaceutical's Other Investors

Psimei Pharmaceutical raised a round of funding on , . Investors include SpringHill Management.

Psimei Pharmaceuticals is developing boron-based drugs for applications in Photon Activation Therapy (PAT). This involves the use of standard radiotherapy to activate boron-based compounds which selec…

Articles about Psimei Pharmaceutical's Other Investors: